SCHEMBL9057841

SCHEMBL9057841

C#CCNCC1=Cc2cc(S(N)(=O)=O)sc2SN1C(C)C

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CA2 P00918 11/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9058810 0.82 CA2 (0.32) CA2
SCHEMBL9058819 0.81 CA2 (0.35) CA2
SCHEMBL9057426 0.77 CA2 (0.37) CA2
SCHEMBL8950599 0.76 CA2 (0.38) CA2
SCHEMBL9058320 0.76 CA2 (0.42) CA2
SCHEMBL9057077 0.75 CA2 (0.44) CA2
SCHEMBL9058101 0.75 CA2 (0.33) CA2
SCHEMBL9058111 0.74 CA2 (0.48) CA2
SCHEMBL9058163 0.70 CA2 (0.46) CA2
SCHEMBL8950412 0.70 CA2 (0.38) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996022099-A1 OPHTHALMIC COMPOSITIONS FOR TREATING GLAUCOMA ALCON LABORATORIES, INC. (US) 1996-07-25 WO disclosed
WO-1995019981-A1 THIENOTHIAZINE SULFONAMIDE DERIVATIVES PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS CARBONIC ANHYDRASE INHIBITORS ALCON LABORATORIES, INC. (US) 1995-07-27 WO disclosed